MedPath

Effects of Prefabricated Foot Orthoses With and Without Metatarsal Pads on Central Metatarsalgia

Not Applicable
Completed
Conditions
Metatarsalgia
Interventions
Device: Prefabricated foot orthoses (PFO) without metatarsal pads
Device: Prefabricated foot orthoses (PFO) with metatarsal pads
Registration Number
NCT06350435
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

Compare the effects of prefabricated foot orthoses with and without metatarsal pads on pain intensity in the 2nd to 4th metatarsophalangeal joints, foot and ankle functional abilities as well as the occurrence of plantar callosities among patients with central metatarsalgia.

Detailed Description

Metatarsalgia is a common condition that affecting about 10% of the general population. Central metatarsalgia involves pathology of the 2nd to 4th metatarsal and their respective metatarsophalangeal joints. This randomized control trial is designed to compare the effects of prefabricated foot orthoses with and without metatarsal pads on pain intensity, foot and ankle functional abilities as well as the occurrence of plantar callosities.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Age ≥ 18 years;
  • Complain of foot pain on the 2nd to 4th MTPJs during walking in shoes, rating the pain intensity as ≥ 50mm on the Visual Analogue Scale (VAS);
  • Able to be ambulant
Read More
Exclusion Criteria
  • Peripheral vascular disease (PVD)
  • Neurological dysfunctions or neuromuscular disorders
  • Active infection, i.e., cellulitis, osteomyelitis, shingles
  • Cognitive impairment
  • History of lower limb surgery and currently undergoing rehabilitation
  • Active ulceration on foot and ankle
  • Current utilization of prescribed insoles
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupPrefabricated foot orthoses (PFO) without metatarsal pads-
Experimental GroupPrefabricated foot orthoses (PFO) with metatarsal pads-
Primary Outcome Measures
NameTimeMethod
Pain intensity at the 2nd to 4th metatarsophalangeal joints during walking in shoes on Visual Analogue ScaleBaseline, a follow-up at 4-8 weeks from baseline

VAS consists of a 100mm-long uninterrupted horizontal line, with 2 verbal description at each end. A score of 0mm represents "no pain" while 100 mm represents "the worst imaginable pain".

Secondary Outcome Measures
NameTimeMethod
Foot and Ankle Outcome Score (FAOS)Baseline, a follow-up at 4-8 weeks from baseline

FAOS consists of 42 questions, which are categorized into 5 subdomains: symptoms, pain, activities of daily living, sports and quality of life. Each question id rated on a 5-point Likert scale, ranging from 0 to 4 and subsequently transformed into a normalized score between 0 and 100. A score of 100 indicates absence of symptoms, while a score of 0 indicates the presence of severe symptoms.

Size of callosities and corns on the plantar area of the 2nd to 4th metatarsophalangeal jointsBaseline, a follow-up at 4-8 weeks from baseline

Trial Locations

Locations (1)

Pamela Youde Nethersole Eastern Hospital

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath